Segment & Geographic Data
Quant-Grade Normalized (live API)
API & CSV Delivery
Antares Pharma Inc's Business Segments
Antares Pharma Inc's reported revenue by business segment and by geographic region, quarterly and annual, normalized against the consolidated income statement. Free below: the top 3 rows per table, this quarter and this fiscal year. Subscriber access adds the full segment history and operating income by segment.
Segment Data As of FY
Reportable Segments
-
Largest Segment
-
Total Revenue
$ 42
Regions Reported
1
Antares Pharma Inc does not report a distinct business-segment axis in its filings - its disaggregated revenue is disclosed by product and service category instead. See the Product & Service breakdown below.
Revenue Share by Region - FY
- Europe3.5%
Revenue by Geographic Region - FY
| Region | Revenue (Millions) | % of Total |
|---|---|---|
| Europe | $ 1 | 3.5% |
Revenue by Product & Service Category - FY
- Product77.3%
- Proprietary Product41.6%
- Partnered Product35.7%
- Royalty12.7%
- Licensing and Development Revenue10.1%
Revenue by Product & Service Category - FY
| Category | Revenue (Millions) | % of Total |
|---|---|---|
| Product | $ 32 | 77.3% |
| Proprietary Product | $ 17 | 41.6% |
| Partnered Product | $ 15 | 35.7% |
Product and service categories are a supplemental disclosure and are not required to sum to consolidated revenue or to the reportable segments above.
2 more categories available
Sign in to unlock the full Antares Pharma Inc dataset.
Description of Antares Pharma Inc
Antares Pharma Inc is a pharmaceutical company headquartered in Ewing, New Jersey. The company focuses on the development and commercialization of self-administered injectable pharmaceuticals. Antares Pharma specializes in developing innovative drug delivery systems that provide patients with more comfortable and convenient ways to administer medication.
Antares Pharma's product portfolio includes multiple self-injection devices and technologies, including the VIBEX QuickShot, a reusable autoinjector, and the OTREXUP, a single-dose, disposable autoinjector for the treatment of rheumatoid arthritis and psoriasis.
The company's technology platform has also been used to develop injectable products for the treatment of osteoporosis, multiple sclerosis, and testosterone replacement therapy. In addition, Antares Pharma has partnerships with several pharmaceutical companies to develop new products using its technology platform. The company also licenses its technology to third-party partners for use in developing new products.
Antares Pharma has a strong focus on research and development, investing heavily in clinical programs that help assess the efficacy and safety of its products. The company's research and development programs are focused on developing products for conditions with significant unmet medical needs, including chronic pain, diabetes, and central nervous system disorders.
Antares Pharma has a strong financial position, with a robust balance sheet and significant cash reserves that allow the company to pursue its research and development initiatives without the need for external financing.
Overall, Antares Pharma is a growing pharmaceutical company with a focus on developing innovative drug delivery systems that provide patients with more comfortable and convenient ways to administer medication. With a strong commitment to research and development, the company is well-positioned to develop new products and technologies that can address the significant unmet medical needs of patients around the world.
Antares Pharma's product portfolio includes multiple self-injection devices and technologies, including the VIBEX QuickShot, a reusable autoinjector, and the OTREXUP, a single-dose, disposable autoinjector for the treatment of rheumatoid arthritis and psoriasis.
The company's technology platform has also been used to develop injectable products for the treatment of osteoporosis, multiple sclerosis, and testosterone replacement therapy. In addition, Antares Pharma has partnerships with several pharmaceutical companies to develop new products using its technology platform. The company also licenses its technology to third-party partners for use in developing new products.
Antares Pharma has a strong focus on research and development, investing heavily in clinical programs that help assess the efficacy and safety of its products. The company's research and development programs are focused on developing products for conditions with significant unmet medical needs, including chronic pain, diabetes, and central nervous system disorders.
Antares Pharma has a strong financial position, with a robust balance sheet and significant cash reserves that allow the company to pursue its research and development initiatives without the need for external financing.
Overall, Antares Pharma is a growing pharmaceutical company with a focus on developing innovative drug delivery systems that provide patients with more comfortable and convenient ways to administer medication. With a strong commitment to research and development, the company is well-positioned to develop new products and technologies that can address the significant unmet medical needs of patients around the world.
Antares Pharma Inc. is a specialty pharmaceutical company that focuses on developing and commercializing innovative drug delivery systems designed to enhance patient care and treatment outcomes. Through its various segments, products, and services, Antares Pharma aims to address the needs of patients and healthcare providers alike.
Segments
1. Proprietary Products:
- Antares Pharma’s proprietary products segment includes a range of self-injection devices, transdermal patches, oral disintegrating tablets, and other drug delivery technologies. These products are developed with cutting-edge methods that aim to enhance the efficacy and safety of medications, thereby improving patient adherence and outcomes.
2. Partnered Products:
- In this segment, Antares Pharma collaborates with other pharmaceutical companies to develop and commercialize both new and existing medications through shared expertise. These partnerships leverage Antares strengths in drug delivery technology and regulatory experience, facilitating a comprehensive approach to drug development and market entry.
Products
1. Prefilled Syringes:
- Antares Pharma manufactures prefilled syringes that deliver a variety of medications, including hormone therapies, pain management drugs, and emergency medications. The prefilled nature of these syringes simplifies the injection process and reduces the time required for preparation, promoting ease of use for patients.
2. Auto-Injectors:
- The company’s line of auto-injectors allows for secure and patient-friendly self-administration of injectable medications. Designed with user-friendliness in mind, these devices include features that cater to various patient needs, ensuring safe and effective delivery of treatments across diverse indications.
3. Transdermal Patches:
- Using the SmartDose® technology, Antares Pharma offers transdermal patches designed for controlled, sustained release of therapeutic agents. This technology ensures that medications are delivered consistently over time, which can significantly enhance patient compliance and treatment efficacy.
4. QuickShot®:
- This portable, handheld auto-injector is specifically tailored for emergency situations, allowing for rapid administration of epinephrine during severe allergic reactions, such as anaphylaxis. The design emphasizes portability and ease of use, aiming to improve patient safety during critical moments.
Services
1. Drug Development Support:
- Antares Pharma provides extensive drug development support to partners, which encompasses formulation development, assistance with preclinical and clinical studies, and navigation through the regulatory landscape. Their expertise ensures that new drugs are developed efficiently and in compliance with all necessary regulations.
2. Contract Manufacturing:
- The company offers contract manufacturing services for drug delivery systems, including the production of prefilled syringes, auto-injectors, and transdermal patches. This service allows partners to leverage Antares Pharmas specialized manufacturing capabilities to produce high-quality delivery systems at scale.
3. Commercialization Services:
- Antares Pharma assists partners in launching their products through comprehensive commercialization services. These include conduct of market research, development of marketing strategies, and training sales personnel. These services are crucial in ensuring that new products achieve successful market entry and sustained growth.
Conclusion
Antares Pharma Inc. has established a diverse portfolio that bridges the gap between innovative drug delivery technologies and effective patient care. By focusing on proprietary and partnered products, alongside providing extensive support services, the company is well-positioned to enhance medication delivery, safety, and patient compliance across a range of therapeutic areas. Their commitment to advancing drug delivery systems translates into improved health outcomes and quality of life for patients utilizing their products and services.
Segments
1. Proprietary Products:
- Antares Pharma’s proprietary products segment includes a range of self-injection devices, transdermal patches, oral disintegrating tablets, and other drug delivery technologies. These products are developed with cutting-edge methods that aim to enhance the efficacy and safety of medications, thereby improving patient adherence and outcomes.
2. Partnered Products:
- In this segment, Antares Pharma collaborates with other pharmaceutical companies to develop and commercialize both new and existing medications through shared expertise. These partnerships leverage Antares strengths in drug delivery technology and regulatory experience, facilitating a comprehensive approach to drug development and market entry.
Products
1. Prefilled Syringes:
- Antares Pharma manufactures prefilled syringes that deliver a variety of medications, including hormone therapies, pain management drugs, and emergency medications. The prefilled nature of these syringes simplifies the injection process and reduces the time required for preparation, promoting ease of use for patients.
2. Auto-Injectors:
- The company’s line of auto-injectors allows for secure and patient-friendly self-administration of injectable medications. Designed with user-friendliness in mind, these devices include features that cater to various patient needs, ensuring safe and effective delivery of treatments across diverse indications.
3. Transdermal Patches:
- Using the SmartDose® technology, Antares Pharma offers transdermal patches designed for controlled, sustained release of therapeutic agents. This technology ensures that medications are delivered consistently over time, which can significantly enhance patient compliance and treatment efficacy.
4. QuickShot®:
- This portable, handheld auto-injector is specifically tailored for emergency situations, allowing for rapid administration of epinephrine during severe allergic reactions, such as anaphylaxis. The design emphasizes portability and ease of use, aiming to improve patient safety during critical moments.
Services
1. Drug Development Support:
- Antares Pharma provides extensive drug development support to partners, which encompasses formulation development, assistance with preclinical and clinical studies, and navigation through the regulatory landscape. Their expertise ensures that new drugs are developed efficiently and in compliance with all necessary regulations.
2. Contract Manufacturing:
- The company offers contract manufacturing services for drug delivery systems, including the production of prefilled syringes, auto-injectors, and transdermal patches. This service allows partners to leverage Antares Pharmas specialized manufacturing capabilities to produce high-quality delivery systems at scale.
3. Commercialization Services:
- Antares Pharma assists partners in launching their products through comprehensive commercialization services. These include conduct of market research, development of marketing strategies, and training sales personnel. These services are crucial in ensuring that new products achieve successful market entry and sustained growth.
Conclusion
Antares Pharma Inc. has established a diverse portfolio that bridges the gap between innovative drug delivery technologies and effective patient care. By focusing on proprietary and partnered products, alongside providing extensive support services, the company is well-positioned to enhance medication delivery, safety, and patient compliance across a range of therapeutic areas. Their commitment to advancing drug delivery systems translates into improved health outcomes and quality of life for patients utilizing their products and services.